CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SyneuRx International (Taiwan) Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SyneuRx International (Taiwan) Corp
20F-10, No.99, Section 1
Xintai 5th Road., Xizhi District
Phone: +886 277422699p:+886 277422699 NEW TAIPEI, 221  Taiwan Fax: +886 226972629f:+886 226972629
Business Summary
SyneuRx International Taiwan Corp is a Taiwan-based company mainly engaged in the development of new drugs. The Company is mainly engaged in the research and development of new drugs for treatment of coronavirus disease (COVID-19), schizophrenia, dementia and depression. Its clinical trials include SNB01 COVID-19 Antiviral, SND13 Adult Schizophrenia Study, SND12 Refractory Schizophrenia and SND11 Adolescent Schizophrenia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Founder GuochuanTsai 12/1/2023 4/2/2013
Director Mau-ChungChang 6/30/2020 6/30/2020
Director Chao-ChingHsu 6/28/2018 6/28/2018
Director JeffreyLu 6/26/2017 6/26/2017
Director Cheng-WenWu 1/1/2021

General Information
Number of Employees: 15 (As of 12/31/2014)
Outstanding Shares: 135,270,000 (As of 6/30/2024)
Shareholders: 6,954
Stock Exchange: TPO
Fax Number: +886 226972629


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024